Melanotan-1, 10mg

Melanotan-1 (MT-1) is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that has been studied in research settings for its interaction with melanocortin receptors, particularly MC1R. It contains a conserved amino acid sequence associated with receptor binding and has demonstrated greater stability compared to endogenous α-MSH in experimental models.

Pigmentation Research

MT-1 has been investigated for its interaction with melanocortin receptors expressed on melanocytes. Activation of these receptors has been associated with intracellular signaling pathways involving cyclic AMP (cAMP), which may influence enzymes related to pigment synthesis under controlled conditions. Research has also explored its relationship with transcriptional regulators involved in melanogenesis, though findings remain model-dependent.

DNA Repair Research

Studies have examined MT-1–associated signaling in the context of cellular responses to DNA damage. Experimental data suggest potential interactions with pathways involved in nucleotide excision repair and related cellular processes. These observations are derived from preclinical models and require further validation.

Inflammatory Pathway Research

Melanocortin receptor signaling has been studied for its association with immune cell activity and inflammatory pathways. Research suggests that receptor engagement may influence cytokine expression and intracellular signaling mechanisms, including those involving NF-κB, in controlled laboratory settings. These findings are context-dependent and remain under investigation.

Oxidative Stress and Cellular Signaling

MT-1 has been examined for its potential role in redox-related pathways and cellular stress responses. Experimental studies have explored its interaction with signaling cascades such as PI3K/Akt and Nrf2, as well as associations with antioxidant enzyme expression. These findings are preliminary and based on in vitro and animal models.

Neurological Research

Research has investigated MT-1 in models related to neuronal signaling, mitochondrial function, and cellular stress responses. Studies have explored its interaction with pathways associated with energy metabolism and cellular viability, though these effects are not fully characterized and remain under investigation.

Hepatic and Systemic Research

MT-1 has also been studied in experimental models of liver function and systemic inflammation. Observations suggest potential associations with immune cell activity and signaling pathways in hepatic tissue under controlled conditions. These findings require further study.

Hematological Research

Preclinical research has explored MT-1’s interaction with erythroid cell populations and related metabolic pathways. These investigations are limited and remain an area of ongoing study.

Melanotan-1 is not approved by the U.S. Food and Drug Administration for human use, and its safety, efficacy, and pharmacological profile have not been established in approved FDA clinical trials. It is not intended to diagnose, treat, cure, or prevent any disease.